Literature DB >> 30551350

Dysregulation of key microRNAs in pancreatic cancer development.

Behzad Baradaran1, Roya Shahbazi2, Monireh Khordadmehr3.   

Abstract

Pancreatic cancer (PC) is mentioned as one of the fourth major cause of cancer-related deaths and also is considered as one of the most malignancies worldwide. Sadly, widely metastasis is frequently observed at the time of PC detection and there are, thereby, almost poor prognosis and ineffective treatment in PC patients. microRNAs (miRNAs), a group of short non-coding RNAs, regulate various cellular and developmental mechanisms, such as cell growth, proliferation, apoptosis, differentiation and angiogenesis. Also, they have essential roles even on the progression of different human and animal diseases. In recent years, extensive studies confirmed the important role of miRNAs in various steps of PC developments, including; tumor initiation, invasion and metastasis, which can use valuably for cancer detection, prognosis and therapy. Therefore, the present study reviewed the new recent investigations in miRNAs involvement in the biology of PC associated with their clinical implications.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Biomarker; Diagnosis; Dysregulation; MicroRNA; Pancreatic cancer

Mesh:

Substances:

Year:  2018        PMID: 30551350     DOI: 10.1016/j.biopha.2018.10.177

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  13 in total

1.  MicroRNA-451a targets caveolin-1 in stomach cancer cells.

Authors:  Yi Wang; Zhenmeng Lin; Jintian Song; Shenghong Wei; Zaisheng Ye; Shu Chen; Yi Zeng; Zhitao Lin; Xiaoling Chen; Luchuan Chen
Journal:  Int J Clin Exp Pathol       Date:  2020-10-01

Review 2.  Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review.

Authors:  Tomas Koltai; Stephan Joel Reshkin; Tiago M A Carvalho; Daria Di Molfetta; Maria Raffaella Greco; Khalid Omer Alfarouk; Rosa Angela Cardone
Journal:  Cancers (Basel)       Date:  2022-05-18       Impact factor: 6.575

3.  Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma.

Authors:  Swati Venkat; Arwen A Tisdale; Johann R Schwarz; Abdulrahman A Alahmari; H Carlo Maurer; Kenneth P Olive; Kevin H Eng; Michael E Feigin
Journal:  Genome Res       Date:  2020-02-06       Impact factor: 9.043

Review 4.  Pancreatic Cancer and Its Microenvironment-Recent Advances and Current Controversies.

Authors:  Kinga B Stopa; Agnieszka A Kusiak; Mateusz D Szopa; Pawel E Ferdek; Monika A Jakubowska
Journal:  Int J Mol Sci       Date:  2020-05-01       Impact factor: 5.923

5.  Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.

Authors:  Cuili Min; Aixia Zhang; Jing Qin
Journal:  Diagn Pathol       Date:  2019-09-23       Impact factor: 2.644

6.  miR-642a-5p partially mediates the effects of lipopolysaccharide on human pulmonary microvascular endothelial cells via eEF2.

Authors:  Liming Fei; Gengyun Sun; Qinghai You
Journal:  FEBS Open Bio       Date:  2020-10-16       Impact factor: 2.792

Review 7.  Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?

Authors:  Robert S O'Neill; Alina Stoita
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

8.  Tumor-Specific miRNA Signatures in Combination with CA19-9 for Liquid Biopsy-Based Detection of PDAC.

Authors:  Min Woo Kim; Hani Koh; Jee Ye Kim; Suji Lee; Hyojung Lee; Young Kim; Ho Kyoung Hwang; Seung Il Kim
Journal:  Int J Mol Sci       Date:  2021-12-19       Impact factor: 5.923

9.  Nickel's Role in Pancreatic Ductal Adenocarcinoma: Potential Involvement of microRNAs.

Authors:  Maria Mortoglou; Luka Manić; Aleksandra Buha Djordjevic; Zorica Bulat; Vladimir Đorđević; Katherine Manis; Elizabeth Valle; Lauren York; David Wallace; Pinar Uysal-Onganer
Journal:  Toxics       Date:  2022-03-21

10.  A panel of 8 miRNAs as a novel diagnostic biomarker in pancreatic cancer.

Authors:  Benyuan Deng; Ming Wang; Zhongwu Liu
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.